These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 36156711
1. [Effectiveness of regional citrate anticoagulation in continuous renal replacement therapy]. Frías A, Gacitúa I, Torres R, Toro L, Segovia E, Alvo M, Rodríguez J, Romero C, Sanhueza ME. Rev Med Chil; 2022 Mar; 150(3):283-288. PubMed ID: 36156711 [Abstract] [Full Text] [Related]
2. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P. Crit Care; 2023 Jun 07; 27(1):222. PubMed ID: 37287084 [Abstract] [Full Text] [Related]
9. Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study. Bianchi NA, Altarelli M, Eckert P, Schneider AG. Blood Purif; 2020 Jun 07; 49(5):567-575. PubMed ID: 32126564 [Abstract] [Full Text] [Related]
10. [Advances in the application of regional citrate anticoagulation for continuous renal replacement therapy in patients with liver failure]. Ning QQ, Meng QH, Zhu YK. Zhonghua Gan Zang Bing Za Zhi; 2018 Jul 20; 26(7):549-552. PubMed ID: 30317782 [Abstract] [Full Text] [Related]
11. The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy. Trakarnvanich T, Sirivongrangson P, Trongtrakul K, Srisawat N. J Artif Organs; 2023 Mar 20; 26(1):53-64. PubMed ID: 35412099 [Abstract] [Full Text] [Related]
12. Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study. Liu D, Zhao J, Xia H, Dong S, Yan S, Zhuang Y, Chen Y, Peng H. Eur J Med Res; 2024 Jan 20; 29(1):72. PubMed ID: 38245802 [Abstract] [Full Text] [Related]
18. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost. Cassina T, Villa M, Soldani-Agnello A, Zini P. Minerva Anestesiol; 2021 Dec 20; 87(12):1309-1319. PubMed ID: 34527405 [Abstract] [Full Text] [Related]
19. Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy - A Safe and Effective Low-Dose Protocol. Poh CB, Tan PC, Kam JW, Siau C, Lim NL, Yeon W, Cui HH, Ding HT, Song XY, Yan P, Chea KL, Liu JS, Chionh CY. Nephrology (Carlton); 2020 Apr 20; 25(4):305-313. PubMed ID: 31469465 [Abstract] [Full Text] [Related]
20. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, Kataoka Y. Cochrane Database Syst Rev; 2020 Dec 14; 12(12):CD012467. PubMed ID: 33314078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]